THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL SUBMISSION.
$179,914N01FY2019DANIH
Technical Resources International, Inc., Bethesda MD
Investigators
Abstract
The objective of this Task Order is to provide support services for the conduct of a clinical study to determine the effect of CBD on the pharmacokinetics of morphine and 2 of its metabolites (morphine-3-glucuronide and morphine-6-glucuronide). In addition, the safety of the combination will be assessed.
View original record on NIH RePORTER →